-+ 0.00%
-+ 0.00%
-+ 0.00%

GENFIT - NANGIBOTIDE DEMONSTRATES FAVORABLE SAFETY PROFILE ACROSS FOUR CLINICAL TRIALS

Reuters·09/14/2026 16:15:55

Please log in to view news